Stock listing

Codexis, Inc.

Selected listing: 0I0X · LSE · USD · GB

Codexis, Inc. (LSE:0I0X), Process Industries. Latest release Sep 28, 2026: Codexis Enters into an Agreement with Pioneering siRNA Drug Innovator to Leverage…

0I0X:LSEUSDGBUpdated October 2, 2026

Ticker: LSE:0I0X
Asset type: Stock
Sector: Process Industries
Industry: Chemicals: Specialty
Exchange: LSE
Currency: USD

About Codexis, Inc.

The company focuses on developing and commercializing innovative enzyme-based solutions for various industries. Codexis aims to enhance product performance and sustainability through its advanced biotechnology platform.

Latest news from Codexis, Inc.

Codexis Enters into an Agreement with Pioneering siRNA Drug Innovator to Leverage the ECO Synthesis Manufacturing Platform to Create Stereo-defined siRNA

September 28, 2026

Codexis to Participate in Cantor Global Healthcare Conference 2026

August 27, 2026

Codexis Reports Second Quarter 2026 Financial Results

August 11, 2026

Codexis Appoints David Butler, PhD, to Strategic Advisory Board

August 3, 2026

Codexis to Report Second Quarter 2026 Financial Results on August 11

July 28, 2026

All Codexis, Inc. news →

Events

Replays

Codexis, Inc. (CDXS) Q2 2026 Earnings Call
Tue, Aug 11, 2026 · 04:30 PM ET
Watch
Codexis, Inc. (CDXS) Q1 2026 Earnings Call
Thu, May 07, 2026 · 04:30 PM ET
Watch
Codexis, Inc. (CDXS) Q4 2025 Earnings Call
Wed, Mar 11, 2026 · 04:30 PM ET
Watch

Research Codexis, Inc.

Codexis, Inc. company profile

View the public company page for Codexis, Inc. on 6ix.

Codexis, Inc. news

Read company news and market updates connected to Codexis, Inc..

Codexis, Inc. investor events

Find investor webinars, events, and replay context for Codexis, Inc..